Prof. Wei Wu | Medicine | Best Researcher Award

Prof. Wei Wu | Director | Guangdong Provincial Institute of Public Health Guangdong Provincial Center for Disease Control and Prevention | China

Dr. Wei Wu is a distinguished public health scientist specializing in labor and environmental hygiene, microbial epidemiology, and health data analytics. His research primarily explores the intersection of gut microbiota, metabolic diseases, and public health, employing advanced population cohort and multi-omics data analysis to uncover novel biomarkers and disease risk genes. Dr. Wu’s studies contribute significantly to understanding nutrient–gut flora–host interactions, guiding innovative therapeutic targets for metabolic and infectious diseases. He has also made substantial contributions to vaccine health economics and hygiene assessment in rail transit systems. As a postgraduate supervisor and active member of multiple national scientific committees, Dr. Wu plays a vital role in shaping public health policy and research in China. His impactful scientific output has earned recognition in leading journals, including Nature Medicine and Microbiome. According to Scopus, he has published 35 documents with over 1,577 citations, an h-index of 13, and his work is widely cited across 1,498 documents. On Google Scholar, his publications have similarly received extensive academic engagement, underscoring his global research influence in environmental and preventive health sciences.

Publication Profile

Scopus | ORCID

Featured Publications

He, Y., Wu, W., Zheng, H. M., Li, P., McDonald, D., Sheng, H. F., et al. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine, 24(10), 1532–1535.

He, Y., Wu, W., Wu, S., Zheng, H. M., Li, P., Sheng, H. F., et al. (2018). Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome, 6(1), 172.

Guo, X., Yan, M., Huang, D., Chen, S., Zhang, D., Li, Z., Yang, X., & Wu, W. (2023). A large scale 16S ribosomal RNA gene amplicon dataset of hand, foot and mouth patients and healthy individuals. Scientific Data, 10(48), 1–6.

Yan, M., Guo, X., Ji, G., Huang, R., Huang, D., Li, Z., Zhang, D., Chen, S., Cao, R., Yang, X., & Wu, W. (2023). Mechanism-based role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis. Frontiers in Immunology, 13(3), 1–13.

Wang, H., Luo, L., & Wu, W. (2023). SAS statistical analysis and applications from introduction to mastery (2nd ed.). Posts & Telecom Press.

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.
Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.
Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.
Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.
Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.